Image courtesy of Transcatheter Technologies GmBH
December 31, 2014 — Transcatheter Technologies GmbH announced that it has expanded the Trinity technology platform to include a transfemoral version.
In September 2014, Transcatheter Technologies disclosed the one year follow up results of its Trinity transapical TAVI system. Unlike currently marketed TAVI systems, the Trinity aortic valve can be positioned or even repositioned after a full implantation in a safe manner. Trinity’s sealing cuff provides results without PVL, a well-known and frequent complication of TAVI. The risk of atrio-ventricular (AV) block has been essentially alleviated because of the supra-annular anchoring of the Trinity valve.
For more information: www.transcatheter-technologies.com/home.html